"At Talley Eye Institute, we know that cooperation is essential in providing quality medical and surgical eye care. Our doctors and staff work as a unified team along with your primary care optometrist. When you have concerns about your vision, turn to your optometrist. When advanced care is needed, ask them about Talley Eye Institute."

During the past decade, Talley Eye conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Talley Eye" are "Diabetic Macular Edema" (1 trials), "Macular Edema" (1 trials), "Retinal Vein Occlusion" (1 trials) and "Wet Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Talley Eye" in a lesser frequency.

Most popular intervention types in "Talley Eye" are "Drug" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (3 trials), "KSI-301" (3 trials) and "Sham Procedure" (3 trials). Other intervention names were less common.

The vast majority of trials in "Talley Eye" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Talley Eye". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Talley Eye, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Talley Eye, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".